Target intelligence / Profile preview

Bitis arietans snake venom serine protease (BaSVSP)

Target
BaSVSP
Molecular classification
Enzyme, Serine protease, S1 family peptidase
01

Overview

Bitis arietans snake venom serine protease (BaSVSP) refers to a group of enzymes found in the venom of the Puff adder, a medically significant viper in Africa. These enzymes primarily disrupt the host hemostatic system by targeting the coagulation cascade, particularly through thrombin-like or fibrinogenolytic activities (PMID: 17467233). By cleaving fibrinogen, BaSVSPs can induce the formation of unstable fibrin clots or lead to the total depletion of fibrinogen, resulting in consumptive coagulopathy and severe systemic hemorrhage (PMID: 30145354). Structurally, these proteases belong to the S1 family of peptidases and utilize a conserved catalytic triad consisting of histidine, aspartate, and serine to perform their proteolytic functions. In a clinical context, BaSVSPs are the primary targets for neutralization by polyvalent antivenoms, such as the SAIMR polyvalent antivenom, which contains antibodies that bind and inactivate these toxins (PMID: 25448304). Furthermore, research into small-molecule inhibitors like nafamostat mesylate has demonstrated their potential as adjunct treatments to inhibit SVSP activity and delay the onset of systemic envenomation effects (PMID: 33035560). Their high specificity for coagulation factors also makes them valuable in diagnostic hematology and as templates for developing novel anticoagulant therapies.

Other names
Puff adder venom serine proteaseBitis arietans SVSPBitis arietans thrombin-like enzymeBitis arietans fibrinogenolytic enzyme
02

Mechanism of action

Antivenoms utilize polyclonal antibodies to bind and neutralize the enzymatic activity of the proteases, while small-molecule inhibitors like nafamostat act as competitive inhibitors of the serine protease catalytic triad.

03

Biological functions

ProteolysisFibrinogenolysisBlood coagulationHemostasis disruptionPlatelet aggregation modulation
04

Disease associations

Snakebite envenomationCoagulopathyHemorrhageThrombosis
05

Safety considerations

Antivenom-induced anaphylaxisSerum sicknessSystemic hemorrhageConsumptive coagulopathyTherapeutic window for inhibitor administration
06

Interacting drugs

SAIMR polyvalent antivenom

3 more in the full profile.

07

Biomarkers

Fibrinogen levelProthrombin time (PT)Activated partial thromboplastin time (aPTT)D-dimer

Beyond the preview

Go deeper on Bitis arietans snake venom serine protease (BaSVSP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bitis arietans snake venom serine protease (BaSVSP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call